Cargando…

Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients

BACKGROUND: Ulcerative colitis (UC) is a chronic lifelong disease. The disease extent of UC can progress over time. This study aimed to assess whether cumulative inflammatory burden (CIB) is associated with disease extension in distal UC (proctitis [E1] and left-sided colitis [E2]) patients, and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Jian, Wang, Xuan, Zhang, Yujie, Xue, Xianmin, Jia, Hui, Wang, Min, Liang, Jie, Wu, Kaichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114755/ https://www.ncbi.nlm.nih.gov/pubmed/35599745 http://dx.doi.org/10.1093/gastro/goac019

Ejemplares similares

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system
por: Bálint, Anita, et al.
Publicado: (2018)

Comparison of the efficiency of different enemas on patients with distal ulcerative colitis
por: Zhang, Yujie, et al.
Publicado: (2019)

Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
por: Shah, Jimil, et al.
Publicado: (2019)

Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis
por: Qi, Jing, et al.
Publicado: (2023)

Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis
por: Xie, Tingbin, et al.
Publicado: (2018)

Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program
por: Sandborn, William J., et al.
Publicado: (2022)

Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
por: Viscido, Angelo, et al.
Publicado: (2022)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Deep learning model for distinguishing Mayo endoscopic subscore 0 and 1 in patients with ulcerative colitis
por: Kim, Ji Eun, et al.
Publicado: (2023)

A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis
por: Kawakatsu, Sonoko, et al.
Publicado: (2021)

Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis
por: Uchihara, Mayu, et al.
Publicado: (2017)

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
por: Goll, Rasmus, et al.
Publicado: (2019)

The Mayo Endoscopic Score Is a Novel Predictive Indicator for Malignant Transformation in Ulcerative Colitis: A Long-Term Follow-Up Multicenter Study
por: Xu, Weimin, et al.
Publicado: (2022)

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
por: Lee, Scott D., et al.
Publicado: (2023)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis
por: Kawashima, Kousaku, et al.
Publicado: (2016)

Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
por: Naegeli, April N, et al.
Publicado: (2021)

Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis
por: Zhang, Xiao-Fei, et al.
Publicado: (2021)

A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
por: Moein, Anita, et al.
Publicado: (2023)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
por: Adibi, Peyman, et al.
Publicado: (2011)

Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis
por: Kumei, Shinsuke, et al.
Publicado: (2021)

Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis
por: Kerur, Basavaraj, et al.
Publicado: (2017)

Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
por: Sakuraba, Akihito, et al.
Publicado: (2021)

Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population
por: Saleem, Asim, et al.
Publicado: (2022)

Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program
por: Dubinsky, Marla C, et al.
Publicado: (2022)

The 2 + 1 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials
por: Ahmad, Harris A., et al.
Publicado: (2016)

Gut Microbiota and Metabolite Changes in Patients With Ulcerative Colitis and Clostridioides difficile Infection
por: Wan, Jian, et al.
Publicado: (2022)

The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023)

Early-Phase Partial Mayo Score following Golimumab Treatment Is Associated with Endoscopic Improvement at 1 Year in Ulcerative Colitis: A post hoc Analysis of PURSUIT-J Randomized Controlled Trial
por: Nagano, Katsumasa, et al.
Publicado: (2022)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
por: Travis, Simon P L, et al.
Publicado: (2011)

Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab
por: Scarozza, Patrizio, et al.
Publicado: (2020)

Propensity score analysis the clinical characteristics of active distal and extensive ulcerative colitis: a retrospective study
por: Ge, Changchang, et al.
Publicado: (2023)

Endoscopic Characteristics of the Healing Process of Ulcerative Colitis
por: Kishi, Hideyuki
Publicado: (1998)

Inter-Observer Agreement of a New Endoscopic Score for Ulcerative Colitis Activity: Preliminary Experience
por: Principi, Mariabeatrice, et al.
Publicado: (2020)

Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis
por: Takenaka, Kazuhiro, et al.
Publicado: (2019)

Endoscopic ultrasonography in the evaluation of condition and prognosis of ulcerative colitis
por: Jin, Rui-Fang, et al.
Publicado: (2022)

Castellano-mayo, mayo-castellano
por: Collard, Howard
Publicado: (1962)

Gegen Qinlian Decoction Relieves Ulcerative Colitis via Adjusting Dysregulated Nrf2/ARE Signaling
por: Lin, Chuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uaknpb9mrvj2hi9r9n431gkbe1